Sun Pharma Recalls Over 10,000 Bottles Of Generic Anti-Depression Drug In USA


Sun Pharma, a drug developing company is now recalling around 10,500 bottles of a generic drug, which is meant for the treatment of the major depressive disorders in the market of the United States followed by a customer complaint.

According to the report of latest enforcement of the Food and Drug Administration (FDA) of the United States, the US arm of the company has been recalling 10,548 bottles of the extended release of bupropion hydrochloride tablets in the market of the United States.

The drug has been used for the purpose of treating the depression and preventing the Season Affective Disorder (SAD) and it is also used for the purpose of helping the people to stop smoking.

According to the US FDA, the company has been recalling the affected lot because of the presence foreign substance, which the customer complaint for the presence of the dark, along with gritty substance has found within the bottle of the medicine, which had been determined for being activated carbon from the desiccant canister inside the bottle of the medicine.

See also  UK Government Ordered to Release Secret Covid-19 Pandemic Planning Files

The company is recalling the product in the strengths of 150 and 200 mg and the company is also recalling 9,804 bottles of the 150 mg strength and 744 bottles of strength 200 mg. the health regulatory of the United States said, the medication had been distributed by the Sun Pharmaceuticals Industries Inc. based in the region of New-Jersey of the United States.